|
๐
|
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.
19 auth.
R. Garrel,
G. Poissonnet,
A. Moyร Plana,
N. Fakhry,
G. Dolivet,
B. Lallemant,
J. Sarini,
S. Vergez,
B. Guelfucci,
O. Choussy,
...
V. Bastit,
F. Richard,
V. Costes,
P. Landais,
F. Perriard,
J. Daurรจs,
D. de Verbizier,
V. Favier,
M. de Boutray
|
6 |
2020 |
6
๐
|
|
๐
|
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
27 auth.
K. Van Baelen,
T. Geukens,
M. Maetens,
V. Tjan โ Heijnen,
C.J. Lord,
S. Linn,
F. Bidard,
F. Richard,
W.W. Yang,
R.E. Steele,
S. Pettitt,
C. Van Ongeval,
M. De Schepper,
E. Isnaldi,
I. Nevelsteen,
...
A. Smeets,
K. Punie,
L. Voorwerk,
H. Wildiers,
G. Floris,
A. Vincent-Salomon,
P. Derksen,
P. Neven,
E. Senkus,
E. Sawyer,
M. Kok,
C. Desmedt
|
5 |
2022 |
5
๐
|
|
๐ฌ
|
Equivalence randomized trial comparing treatment based on sentinel node biopsy versus neck dissection in operable T1-T2N0 oral and oropharyngeal cancer.
R. Garrel,
F. Perriard,
V. Favier,
F. Richard,
J. Daurรจs,
M. D. Boutray
|
2 |
2020 |
2
๐ฌ
|
|
๐
|
170P ฮฒ2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled on the NCCTG-N9831 (Alliance) trial
12 auth.
R. Caparica,
Yaohua Ma,
C. Angelis,
F. Richard,
C. Desmedt,
A. Awada,
...
M. Piccart,
E. Perez,
A. Moreno-Aspitia,
S. Badve,
E. Thompson,
E. Azambuja
|
0 |
2020 |
0
๐
|
|
๐
|
Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785].
27 auth.
K. Van Baelen,
T. Geukens,
M. Maetens,
V. Tjan-Heijnen,
C. Lord,
S. Linn,
F. Bidard,
F. Richard,
W. W. Yang,
R. E. Steele,
S. Pettitt,
C. Van Ongeval,
M. De Schepper,
E. Isnaldi,
I. Nevelsteen,
...
A. Smeets,
K. Punie,
L. Voorwerk,
H. Wildiers,
G. Floris,
A. Vincent Salomon,
P. Derksen,
P. Neven,
E. Senkus,
E. Sawyer,
M. Kok,
C. Desmedt
|
0 |
2022 |
0
๐
|
|
๐ฆ
|
14P Comparison of single-cell ERBB2 mRNA expression levels with HER2 status by immunohistochemistry reveals heterogeneity of the HER2-low status
16 auth.
F. Richard,
M. De Schepper,
T. Geukens,
H. Vos,
A. Bassez,
H.L. Nguyen,
M. Maetens,
L. Wang,
I. Nevelsteen,
H. Wildiers,
...
P. Neven,
K. Punie,
A. Smeets,
D. Lambrechts,
G. Floris,
C. Desmedt
|
0 |
2023 |
0
๐ฆ
|
|
๐
|
52P Clinical characterization of HER2 low in patients with lobular breast cancer (ILC)
20 auth.
K. Van Baelen,
H.L. Nguyen,
F. Richard,
G. Zels,
M. Karsten,
G. Marta,
P. Vermeulen,
L. Dirix,
H. Wuyts,
A. D. Dordevic,
...
E. de Azambuja,
D. Larsimont,
M. Maetens,
E. Biganzoli,
H. Wildiers,
A. Smeets,
I. Nevelsteen,
P. Neven,
G. Floris,
C. Desmedt
|
0 |
2023 |
0
๐
|
